Company: HRTX
Filing Date: 2025-08-15
Form Type: 8-K
Source: 0000950170-25-109234
Chunk: 6

Company: HERON THERAPEUTICS, INC. /DE/
Filing Date: 2025-08-15
Form: 8-K
Item: Item 3.03
Chunk 6
---
 redeemable, the Company may amend or supplement the Plan in any manner that does not adversely affect the interests of the holders of the Rights (other than an Acquiring Person).

Item 5.03 Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year.

The terms, rights, obligations and preferences of the Preferred Stock are set forth in the Certificate of Designation of Series B Preferred Stock (the “ Certificate of Designation”), which was filed with the Secretary of State of the State of Delaware on August 14, 2025. The following description of the Preferred Stock does not purport to be complete and is qualified in its entirety by reference to the Certificate of Designation. A copy of the Certificate of Designation is attached hereto as Exhibit 3.1 and is incorporated herein by reference.

Shares of Preferred Stock purchasable upon exercise of the Rights will not be redeemable. Each share of Preferred Stock will be entitled, when, as and if declared, to a minimum preferential quarterly dividend payment of the greater of (a) $1.00 per share, and (b) an amount equal to 1,000 times the dividend declared per share of Common Stock. In the event of liquidation, dissolution or winding up of the Company, the holders of the Preferred Stock will be entitled to a preferential payment equal to $1,000 per share of Preferred Stock, plus an amount equal to accrued and unpaid dividends and distributions thereon, whether or not declared, to the date of such payment, before any distribution is made on securities ranking junior to the Preferred Stock. Each share of Preferred Stock will have 1,000 votes, voting